title: Introduction: Antibody-targeted therapy special issue.
authors.affiliation: Editor-in-Chief.
authors.forename: Tadamitsu
authors.initials: T
authors.lastname: Kishimoto
mesh_terms: D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000276:immunology / Q000628:therapy; D060908:CTLA-4 Antigen / Q000276:immunology; D006801:Humans; D007167:Immunotherapy / Q000379:methods*; D039041:Integrin alpha4beta1 / Q000276:immunology; D015850:Interleukin-6 / Q000276:immunology; D015459:Leukemia-Lymphoma, Adult T-Cell / Q000276:immunology / Q000628:therapy; D008545:Melanoma / Q000276:immunology / Q000628:therapy; D058990:Molecular Targeted Therapy / Q000379:methods*; D009103:Multiple Sclerosis / Q000276:immunology / Q000628:therapy; D061026:Programmed Cell Death 1 Receptor / Q000276:immunology; D054398:Receptors, CCR4 / Q000276:immunology
chemical_list: D000911:Antibodies, Monoclonal; C515354:CCR4 protein, human; D060908:CTLA-4 Antigen; D039041:Integrin alpha4beta1; D015850:Interleukin-6; C105992:PDCD1 protein, human; D061026:Programmed Cell Death 1 Receptor; D054398:Receptors, CCR4